Evidence map›Paper›PMID 24859739›Full record

ArticleJournal of lipid research2014

Enhanced synthesis of saturated phospholipids is associated with ER stress and lipotoxicity in palmitate treated hepatic cells.

Alexandra K Leamy, Robert A Egnatchik, Masakazu Shiota, Pavlina T Ivanova, David S Myers, H Alex Brown, Jamey D Young

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 126 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. A protein-lipid complex that detoxifies free fatty acids.BioEssays : news and reviews in molecular, cellular and developmental biology · 2023
    Article
  19. Article
  20. Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Alexandra K LeamyDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN 37235-1604.
Robert A EgnatchikDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN 37235-1604.
Masakazu ShiotaDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN 37235-1604.
Pavlina T IvanovaDepartment of Pharmacology, Vanderbilt University Medical Center, Vanderbilt University, Nashville, TN 37235-1604.
David S MyersDepartment of Pharmacology, Vanderbilt University Medical Center, Vanderbilt University, Nashville, TN 37235-1604.
H Alex BrownDepartment of Pharmacology, Vanderbilt University Medical Center, Vanderbilt University, Nashville, TN 37235-1604 Department of Biochemistry, Vanderbilt University, Nashville, TN 37235-1604 Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, TN 37235-1604.
Jamey D YoungDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN 37235-1604 Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN 37235-1604.
Vanderbilt University · USVanderbilt University Medical Center · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI STACIE B DUSETZINA · 1995 to 2026
$172.8M
STEROL LIPIDSU54GM069338 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DENNIS, EDWARD A · 2003 to 2013
$72.2M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ALVIN C POWERS · 2012 to 2026
$29.3M
TRANSGENIC MOUSE/ ES CELL SHARES RESOURCESP60DK020593 · NIDDK · VANDERBILT UNIVERSITY · PI POWERS, ALVIN C · 1986 to 2011
$28.1M
Shop Module CoreP30EY008126 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI David J. Calkins · 1989 to 2026
$19.6M
THREE-TIERED PREVENTION MODEL TO BETTER SERVE ALL STUDENP30HD015052 · NICHD · VANDERBILT UNIVERSITY · PI HARRELL, FRANK E. · 1985 to 2014
$18.6M
Vanderbilt Mouse Metabolic Physiology CenterU24DK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2001 to 2015
$14.9M
Liver Glucose Flux in Obesity and DiabetesR01DK060667 · NIDDK · VANDERBILT UNIVERSITY · PI SHIOTA, MASAKAZU · 2002 to 2016
$4.0M
Liver glucose Flux in Obesity and DiabetesR56DK060667 · NIDDK · VANDERBILT UNIVERSITY · PI SHIOTA, MASAKAZU · 2007 to 2007
$282k
NCI NIH HHS P30 CA068485NEI NIH HHS P30 EY008126NICHD NIH HHS P30 HD015052NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P30 DK058404NIDDK NIH HHS P60 DK020593NIDDK NIH HHS R01 DK060667NIDDK NIH HHS R56 DK060667NIDDK NIH HHS U24 DK059637NIGMS NIH HHS U54 GM069338
6 · The paper itself

Abstract

High levels of saturated FAs (SFAs) are acutely toxic to a variety of cell types, including hepatocytes, and have been associated with diseases such as type 2 diabetes and nonalcoholic fatty liver disease. SFA accumulation has been previously shown to degrade endoplasmic reticulum (ER) function leading to other manifestations of the lipoapoptotic cascade. We hypothesized that dysfunctional phospholipid (PL) metabolism is an initiating factor in this ER stress response. Treatment of either primary hepatocytes or H4IIEC3 cells with the SFA palmitate resulted in dramatic dilation of the ER membrane, coinciding with other markers of organelle dysfunction. This was accompanied by increased de novo glycerolipid synthesis, significant elevation of dipalmitoyl phosphatidic acid, diacylglycerol, and total PL content in H4IIEC3 cells. Supplementation with oleate (OA) reversed these markers of palmitate (PA)-induced lipotoxicity. OA/PA cotreatment modulated the distribution of PA between lipid classes, increasing the flux toward triacylglycerols while reducing its incorporation into PLs. Similar trends were demonstrated in both primary hepatocytes and the H4IIEC3 hepatoma cell line. Overall, these findings suggest that modifying the FA composition of structural PLs can protect hepatocytes from PA-induced ER stress and associated lipotoxicity.

Indexed as

AnimalsCell Line, TumorEndoplasmic Reticulum StressHepatocytesLiverPalmitic AcidPhospholipidsRatsRats, Sprague-DawleyPalmitic AcidPhospholipidsendoplasmic reticulum stresslipoapoptosismembrane compositionnonalcoholic fatty liver diseasephospholipid metabolismsaturated fatty acidstriacylglycerol synthesis

Identifiers

PMID24859739
PMCPMC4076085
OpenAlexW2169333619

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.